AzTrials
AzTrials

Protein Supplementation4BettProNCT05228236

Plant Based Protein and Whey Protein: Effects on Body Composition and Performance

A study testing Plant based protein and Whey protein in people with Protein Supplementation, run by Bettery S.A. at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to investigate the effects of a newly developed plant-based protein blend regarding health and safety, body composition, and performance on healthy and physically active adult individuals, specifically team sports athletes. Read more about this study

Who is it for?
Ages 18 to 35 years, men onlyHealthy volunteers can take part
Conditions the study is for
Protein Supplementation
What is being tested?
Plant based protein and Whey protein
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 sitePortugal
Study dates
1 Sep 2021to 10 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Subjects currently engaged in a Futsal training program in a competition team, currently engaged in practice for at least 1 year and at least 3 times per week.

Who cannot join

  • Individuals taking any type of drug (including anabolic steroids), medicines or supplements that may enhance body composition or performance, 3 months prior to the beginning of the trial.
  • Clinical diagnose of a disease that might compromise tolerance to the supplements or influence body composition or performance.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Bettery S.A.

    Oeiras, Porto Salvo, 2740-262

Other trials in Portugal

About this study

Official title: Comparing the Effects of Plant Based Protein vs. Whey Protein on Performance and Body Composition of Futsal Players

This study aimed to investigate the effects of a newly developed plant-based protein blend regarding health and safety, body composition, and performance on healthy and physically active adult individuals, specifically team sports athletes. A randomized, double-blind, controlled trial was used to compare the effects of the plant-based protein versus whey protein, after an 8-week supplementation protocol, on body composition, biochemical markers, muscle strength and power, as well as aerobic performance in male futsal players. The working hypothesis is that this special blend of plant-based protein will be equivalent to whey protein, not only regarding body composition and performance, but also insofar as health and safety at the biochemical and physiological level.

Read the detailed description

A randomized, double-blind, controlled trial was performed to investigate health and safety following supplementation with a newly developed plant-based protein blend and to compare the effects of this plant-based protein versus whey protein, after an 8-week supplementation protocol, on body composition and performance. Prior to intervention, volunteers' general health and ability to participate in the study were assessed. The study involved 50 male futsal players currently engaged in a training program and competing. Before engaging the 8-week supplementation protocol, participants underwent measurements of body composition, strength and power, and aerobic performance, as well as a full profile of biochemical health markers, and assessment of food and fluid intake. Evaluations were repeated after 4 weeks, for follow up and to detect potential compliance issues, and after 8 weeks of supplementation. Assessments took place in the morning (starting at 7:00 a.m.) after an overnight fast, except for the performance tests, which were performed following consumption of a standard, meal replacement bar.

Anthropometry and Body Composition - Wearing minimal clothing and no shoes, participants had their weight and height measured on a scale and stadiometer (Seca, Hamburg, Germany), respectively. Body composition, namely bone mineral content, fat mass and fat free mass, were evaluated by dual energy X-ray absorptiometry (DXA) (Horizon Wi, Hologic, Waltham, USA) and skeletal muscle through the evaluation of the muscle thickness of the rectus femoris by ultrasonography (model WED-180 HL, Shenzhen,China). Total body water and its intra and extracellular compartments were estimated from whole body resistance (R) and reactance (Xc), measured through bioelectrical impedance analysis (BIA), using a single frequency device of 50 kHz (BIA-101, RJL/Akern Systems, Firenze, Italy). From the raw R and Xc data, the phase angle was additionally determined, using the Akern Software.

Muscle Strength and Power, and Aerobic Performance - Strength was assessed using the handgrip strength test, as well as the back squat and bench press 1 repetition maximum (1 RM). The handgrip strength test was used to evaluate the maximal isometric force of the muscles of the hand and forearm. Using a portable hand dynamometer (JAMAR, Sammons Preston, Bolingbrook, IL, USA), participants were assessed for both hands alternately, in a stand-up position. The maximal force generated out of 3 attempts was considered for analysis. Additionally, muscle strength was evaluated by 1RM back squat and bench press in a Multipower machine, using a velocity-based training device (Vitruve Encoder, Madrid, Spain). Muscle power was assessed during maximal cycling (Wingate test) and jumping movements. During the Wingate test, participants were instructed to cycle (Monark 894 Peak Bike, Vansbro, Sweden) against a predetermined resistance (7.5% body weight), as fast as possible, for 30 seconds. Vertical jumps, namely the squat jump, countermovement jumps using both legs and single legs, as well as the Abalakov countermovement jump, were performed on a multicomponent force platform (Chronojump Boscosystem, Barcelona, Spain) interfaced with a computer. The best out of 3 attempts was also considered for analysis of this methodology. Aerobic performance was assessed by VO2peak and maximal aerobic speed (MAS), determined using a breath-by-breath gas analyzer (Quark, Cosmed, Italy) in an incremental test performed on a treadmill (Axelero, MEDEN-INMED, Koszalin, Poland). After 3 minutes of warm-up at 5 km/h, participants began the test at 6 km/h and 2% inclination. Each minute, the speed increased 1 km/h until volitional exhaustion. The VO2peak was considered the highest 30 sec average value of VO2 and MAS, the speed at the last completed stage.

All tasks were performed by the participants with direct supervision of sport scientists and/or exercise physiologists, with prior knowledge of the methodologies, and experience handling the equipments and corresponding softwares.

Biochemical Markers - For biochemical health markers, saliva and whole blood, in EDTA tubes, were collected per the standard protocols. . From whole blood, plasma was separated when necessary. Blood measurements included hematocrit, glucose, C-reactive protein (CRP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), and creatinine, using spectrophotometry techniques in an automated equipment (Vario Photometer II DP310, Diglobal Gmbh, Berlin, Germany). Saliva was collected for cortisol evaluation in Enzyme-Linked Immunosorbent Assay (ELISA) commercial kits (Salimetrics, PA, USA).

Nutritional Assessment - Following extensive verbal and written instructions, diet control and food patterns were characterized using 3-day food records (2 non-consecutive weekdays and 1 weekend day). Participants were instructed to maintain their dietary pattern for the 8 weeks of the study. Energy, macronutrient, and micronutrient intake were quantified using a dietary analysis software (Nutritics Research Edition (v5.09), Dublin, Ireland).

Randomization and Supplementation - Eligible participants were assigned to one of the two arms of the study using a covariate adaptive randomization procedure considering the covariates age, handgrip strength, whole body fat-free mass, and whole-body fat mass percentage. The investigator responsible for the sample randomization and supplements distribution was not directly involved in participants' eligibility interview or data collection. The supplementation protocol was similar for both the plant-based and whey protein, with the uptake of a single dose of ~30 g occurring 30-60 min after physical practice on training days or 30-60 min before bedtime on rest days. Supplementation compliance was assessed by questionnaire at the end of weeks 4 and 8.

Sample Size Justification - Previous, similar studies showed no differences between the abovementioned supplements regarding the analyzed variables of interest. In cases where there are no differences between the arms of the study, an effect size does not exist, so a power analysis is not a valid approach. As our hypothesis is that there will be no difference between the newly developed plant-based protein blend and whey protein, we can consider a non-inferiority trial and, therefore, our sample size can be similar to that of previous studies. Additionally, despite the time course of muscle hypertrophy not being exactly known, an 8-week intervention would be considered the minimum timeline for true hypertrophy to be detectable/measurable after 6-8 weeks of resistance training (using medical imageology i.e., ultrasound). Furthermore, it has been reported that to detect hypertrophy differences following supplementation with proteins of different quality, the number of subjects needed should be in the range of at least 25 per group. We have chosen to go with a robust approach. Therefore, our proposed sample size is of 25 participants per group.

Statistics - All statistical analyses are being carried out using IBM SPSS Statistics (Version 25.0, NY, IBM). Basic descriptive data were run to characterize the study participants. All variables were checked for normality, using Kolmogorov-Smirnov test. Participants were assigned to either a plant-based protein (n = 25) or animal protein group (n = 25), based on handgrip strength, age, fat mass or fat-free mass using a stratified random assignment. Independent Sample T tests will be applied to compare means between supplementation groups, at baseline. Time and time-by-group interactions will be evaluated by repeated-measures ANOVA. The equality of the matrix of variance and sphericity will be explored with the Levene F test and Mauchly's test, respectively. Overall significance level for α will be set at p ≤ 0.05.

Being tested
Plant based protein, Whey protein
Keywords
Plant-based Protein, Body composition, Physical Performance, Biochemical Health Markers, Supplementation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Plant based proteinDietary supplement

    A single dose of ~30 g of a plant-based protein blend was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days.

  • Whey proteinDietary supplement

    A single dose of ~30 g of whey protein was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days.

Study groups in NCT05228236
Study groupRoleWhat they receive
Plant based proteinExperimentalNot described
Receives: Dietary Supplement: Plant based protein
Whey ProteinExperimentalNot described
Receives: Dietary Supplement: Whey protein

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Body composition parameter - change in fat free mass (FFM)

    FFM (kg) was assessed by dual energy X-ray absorptiometry

    Measured: Baseline, week 4 and week 8

  2. Body composition parameter - change in fat mass (FM)

    FM (%) was assessed by dual energy X-ray absorptiometry

    Measured: Baseline, week 4 and week 8

  3. Body composition parameter - change in muscle thickness

    muscle thickness of the rectus femoris (mm) was assessed by ultrasonography

    Measured: Baseline, week 4 and week 8

  4. Body composition parameter - change in body water

    total body water, intracellular water and extracellular water (L) were assessed by bioelectrical impedance analysis

    Measured: Baseline, week 4 and week 8

  5. Performance parameter - change in strength

    Maximal isometric forearm strength (N) was assessed using a handgrip dynamometer

    Measured: Baseline, week 4 and week 8

  6. Performance parameter - change in maximum strength

    Maximum strength (kg) was predicted from 1-RM in back squat and bench press exercises using a Multipower machine withVitruve technology

    Measured: Baseline, week 4 and week 8

  7. Performance parameter - change in peak power

    Muscle power (Watt) was assessed with a supramaximal cycling test on cycle ergometer

    Measured: Baseline, week 4 and week 8

  8. Performance parameter - change in jump height

    Vertical jump height (cm) was assessed on a multicomponent force platform interfaced with the Chronojump software

    Measured: Baseline, week 4 and week 8

  9. Aerobic performance - change in Oxygen uptake

    VO2peak (mL.kg-1.min-1) was assessed using breath-by-breath gas analyzer in an incremental test performed on a treadmill

    Measured: Baseline, week 4 and week 8

  10. Aerobic performance - change in Oxygen uptake

    Maximal aerobic speed (km/h) was assessed in an incremental test performed on a treadmill

    Measured: Baseline, week 4 and week 8

  11. biochemical health markers - change in cortisol

    Salivary cortisol was assessed using spectrophotometry techniques in an automated equipment.

    Measured: Baseline, week 4 and week 8

  12. biochemical health markers - change in creatinine

    plasma creatinine was assessed using spectrophotometry techniques in an automated equipment.

    Measured: Baseline, week 4 and week 8

  13. biochemical health markers - change creatine kinase

    plasma creatine kinase was assessed using spectrophotometry techniques in an automated equipment.

    Measured: Baseline, week 4 and week 8

  14. biochemical health markers - change in glucose

    plasma glucose was assessed using spectrophotometry techniques in an automated equipment.

    Measured: Baseline, week 4 and week 8

  15. biochemical health markers - change in C reactive protein

    plasma C Reactive Protein was assessed using spectrophotometry techniques in an automated equipment.

    Measured: Baseline, week 4 and week 8

  16. biochemical health markers - change in Aspartate Aminotransferase

    plasma Aspartate Aminotransferase was assessed using spectrophotometry techniques in an automated equipment.

    Measured: Baseline, week 4 and week 8

  17. biochemical health markers - change in alanine aminotransferase

    Plasma alanine aminotransferase was assessed using spectrophotometry techniques in an automated equipment.

    Measured: Baseline, week 4 and week 8

Secondary outcomes (2)
  1. Body composition parameter - change in phase angle

    Phase angle (degree) was assessed by bioelectrical impedance analysis

    Measured: Baseline, week 4 and week 8

  2. Body composition parameter - change of visceral fat

    Visceral fat (kg) was assessed by dual energy X-ray absorptiometry

    Measured: Baseline, week 4 and week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2022
  2. Study start1 Sep 2021
  3. Primary completion10 Dec 2021
  4. Study completion10 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05228236
Sponsor's protocol ID
BetteryLifeLab4BP
Acronym
4BettPro
Status last verified
Jan 2022
First submitted
13 Jan 2022
Last updated
8 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Plant based protein and Whey protein in people with Protein Supplementation, run by Bettery S.A. at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Body composition parameter - change in fat free mass (FFM) (time frame: Baseline, week 4 and week 8). The study lists 17 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in